Vinblastine
28 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
28
Total Reports
6
Deaths Reported
2140.0%
Death Rate
Active Ingredients
Vinblastine
Administration Routes
UnknownIntravenous
Species Affected
Dog 25
Cat 3
Most Affected Breeds
Retriever - Labrador 6
Pug 3
Domestic Shorthair 3
Shih Tzu 3
Retriever - Golden 3
Bulldog - French 2
Mixed (Dog) 2
Terrier - Boston 1
Shar Pei 1
Bichon Frise 1
Most Reported Reactions
Diarrhoea 5
Elevated serum alkaline phosphatase (SAP) 5
Lethargy (see also Central nervous system depression in 'Neurological') 5
Elevated alanine aminotransferase (ALT) 4
Vomiting 4
Decreased appetite 4
Death by euthanasia 4
Emesis 3
Elevated liver enzymes 3
Other abnormal test result NOS 3
Thrombocytopenia 3
Anaemia NOS 3
Outcome Breakdown
Ongoing
17 (58.6%)
Euthanized
5 (17.2%)
Recovered/Normal
4 (13.8%)
Died
2 (6.9%)
Outcome Unknown
1 (3.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.